TY - JOUR
T1 - Applicability of non-halogenated methyl propionate to microencapsulation
AU - Kang, Jukyung
AU - Sah, Edel
AU - Sah, Hongkee
N1 - Funding Information:
This study was supported by a grant from the Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A092018). The authors report no declaration of interest. The authors alone are responsible for the content and writing of the article.
PY - 2014
Y1 - 2014
N2 - Applicability of methyl propionate to microencapsulation was evaluated with regard to volatility, capability of forming emulsions, and their quality. An emulsion-based technique was then developed to encapsulate progesterone into poly-d,l-lactide-co-glycolide microspheres. Their characteristics were compared with those prepared using ethyl acetate. Our results demonstrated that methyl propionate had greater evaporative tendency and less water miscibility than ethyl acetate did. The former allowed us to prepare good microspheres. Their average volume mean diameter was 68.3 ± 1.7 μm with a span index of 0.91 ± 0.13. Progesterone did not undergo polymorphic transition during microencapsulation, and its encapsulation efficiency ranged from 41.80 ± 1.83 to 85.64 ± 1.95%. Residual methyl propionate in various microspheres was found to be 0.97 ± 0.03 to 1.54 ± 0.07%. Such microsphere characteristics were quite similar to those prepared by the ethyl acetate-based microencapsulation process. Overall, our findings reflect that methyl propionate has a potential to become an invaluable solvent for microencapsulation.
AB - Applicability of methyl propionate to microencapsulation was evaluated with regard to volatility, capability of forming emulsions, and their quality. An emulsion-based technique was then developed to encapsulate progesterone into poly-d,l-lactide-co-glycolide microspheres. Their characteristics were compared with those prepared using ethyl acetate. Our results demonstrated that methyl propionate had greater evaporative tendency and less water miscibility than ethyl acetate did. The former allowed us to prepare good microspheres. Their average volume mean diameter was 68.3 ± 1.7 μm with a span index of 0.91 ± 0.13. Progesterone did not undergo polymorphic transition during microencapsulation, and its encapsulation efficiency ranged from 41.80 ± 1.83 to 85.64 ± 1.95%. Residual methyl propionate in various microspheres was found to be 0.97 ± 0.03 to 1.54 ± 0.07%. Such microsphere characteristics were quite similar to those prepared by the ethyl acetate-based microencapsulation process. Overall, our findings reflect that methyl propionate has a potential to become an invaluable solvent for microencapsulation.
KW - Injectable dosage form
KW - Methyl propionate
KW - Non-halogenated solvents
KW - Poly-d,l-lactide-co-glycolide
UR - http://www.scopus.com/inward/record.url?scp=84901308885&partnerID=8YFLogxK
U2 - 10.3109/02652048.2013.843729
DO - 10.3109/02652048.2013.843729
M3 - Article
C2 - 24175715
AN - SCOPUS:84901308885
SN - 0265-2048
VL - 31
SP - 323
EP - 332
JO - Journal of Microencapsulation
JF - Journal of Microencapsulation
IS - 4
ER -